Glaukos Corporation
GKOS
Rang in Aktien
#2087
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Aktienkurs
$166.79
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$9.84B
Veränderung (1 Tag)
1.44%
Veränderung (1 Jahr)
109.88%
Land
US
Handel Glaukos Corporation (GKOS)
Kategorie
Healthcare
P/S-Verhältnis für Glaukos Corporation (GKOS)
P/S-Verhältnis zum October 2026 TTM: 16.16
Laut den neuesten Finanzberichten und dem Aktienkurs von Glaukos Corporation beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 16.16. Am Ende des Jahres 2023 lag das P/S-Verhältnis bei 12.23.
P/S-Verlauf für Glaukos Corporation von 2012 bis 2026
P/S-Verhältnis zum Jahresende
| Jahr | P/S-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 16.16 | -21.67% |
| 2024 | 20.63 | 68.61% |
| 2023 | 12.23 | 66.98% |
| 2022 | 7.33 | 4.41% |
| 2021 | 7.02 | -52.86% |
| 2020 | 14.89 | 73.38% |
| 2019 | 8.59 | -20.84% |
| 2018 | 10.85 | 95.86% |
| 2017 | 5.54 | -43.91% |
| 2016 | 9.87 | 64.08% |
| 2015 | 6.02 | -64.69% |
| 2014 | 17.04 | -54.05% |
| 2013 | 37.09 | 45.31% |
| 2012 | 25.53 | 0.00% |
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/S-Verhältnis | P/S-Verhältnis-Differenz | Land |
|---|---|---|---|
| 3.82 | -76.33% |
US
|
|
| 2.78 | -82.77% |
IE
|
|
| 4.18 | -74.14% |
US
|
|
| 2.97 | -81.62% |
US
|
|
| - | - |
DE
|
